SRK-015

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular AtrophyNCT03921528Scholar Rock, Inc.Phase 2Completed2021-01-19Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.